FFCP PHASE1:Mm9::chr14:56825210..56825237,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=106|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr14:56825210..56825237,+|id=chr14:56825210..56825237,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0006834!3.06e-23!1;UBERON:0005795!6.55e-23!4;UBERON:0000995!6.55e-23!4;UBERON:0003975!1.42e-18!5;UBERON:0001987!3.12e-12!2;UBERON:0003124!3.12e-12!2;UBERON:0004340!3.12e-12!2;UBERON:0003134!4.89e-12!8;UBERON:0004175!8.07e-11!9;UBERON:0000474!8.07e-11!9;UBERON:0003100!4.82e-09!11;UBERON:0005631!1.34e-08!3;UBERON:0000478!1.34e-08!3;UBERON:0000158!1.34e-08!3|ontology_enrichment_uberon_v019_2=UBERON:0006834,2.74e-44,1;UBERON:0005795,4.54e-44,4;UBERON:0000995,4.54e-44,4;UBERON:0003975,1.42e-35,5;UBERON:0003134,8.41e-23,8;UBERON:0001987,9.50e-23,2;UBERON:0003124,9.50e-23,2;UBERON:0004340,9.50e-23,2;UBERON:0004175,1.98e-20,9;UBERON:0000474,1.98e-20,9;UBERON:0003100,5.67e-17,11;UBERON:0005631,1.12e-15,3;UBERON:0000478,1.12e-15,3;UBERON:0000158,1.12e-15,3;UBERON:0003133,1.75e-08,24;UBERON:0005156,6.33e-08,26;UBERON:0000990,6.33e-08,26|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.264450566663544,0,0.232236671860439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.57080782578389,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.516057839704,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr14:56825210..56825237,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=106 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr14:56825210..56825237,+ | |||
|description=CAGE_peak_at_chr14:56825210..56825237,+ | |||
|id=chr14:56825210..56825237,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0006834!3.06e-23!1;UBERON:0005795!6.55e-23!4;UBERON:0000995!6.55e-23!4;UBERON:0003975!1.42e-18!5;UBERON:0001987!3.12e-12!2;UBERON:0003124!3.12e-12!2;UBERON:0004340!3.12e-12!2;UBERON:0003134!4.89e-12!8;UBERON:0004175!8.07e-11!9;UBERON:0000474!8.07e-11!9;UBERON:0003100!4.82e-09!11;UBERON:0005631!1.34e-08!3;UBERON:0000478!1.34e-08!3;UBERON:0000158!1.34e-08!3 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0006834,2.74e-44,1;UBERON:0005795,4.54e-44,4;UBERON:0000995,4.54e-44,4;UBERON:0003975,1.42e-35,5;UBERON:0003134,8.41e-23,8;UBERON:0001987,9.50e-23,2;UBERON:0003124,9.50e-23,2;UBERON:0004340,9.50e-23,2;UBERON:0004175,1.98e-20,9;UBERON:0000474,1.98e-20,9;UBERON:0003100,5.67e-17,11;UBERON:0005631,1.12e-15,3;UBERON:0000478,1.12e-15,3;UBERON:0000158,1.12e-15,3;UBERON:0003133,1.75e-08,24;UBERON:0005156,6.33e-08,26;UBERON:0000990,6.33e-08,26 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.264450566663544,0,0.232236671860439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.57080782578389,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,16.516057839704,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr14:56825210..56825237,+ | |||
}} |
Latest revision as of 13:12, 4 August 2015
Short description: | p@chr14:56825210..56825237, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr14:56825210..56825237, + |
Coexpression cluster: | MCL_coexpression_mm9:106 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
uterus or analog | 2.74e-44 | 1 |
embryonic uterus | 4.54e-44 | 4 |
uterus | 4.54e-44 | 4 |
internal female genitalia | 1.42e-35 | 5 |
female reproductive organ | 8.41e-23 | 8 |
placenta | 9.50e-23 | 2 |
chorion | 9.50e-23 | 2 |
allantois | 9.50e-23 | 2 |
internal genitalia | 1.98e-20 | 9 |
female reproductive system | 1.98e-20 | 9 |
female organism | 5.67e-17 | 11 |
extraembryonic membrane | 1.12e-15 | 3 |
extraembryonic structure | 1.12e-15 | 3 |
membranous layer | 1.12e-15 | 3 |
reproductive organ | 1.75e-08 | 24 |
reproductive structure | 6.33e-08 | 26 |
reproductive system | 6.33e-08 | 26 |